Long‐term outcome of ablation for anal HSIL: Achieving HSIL‐free status is key—A UK‐based retrospective cohort study
T Cuming, K Rozemeijer, E Farrow, C Cappello, B Wait, M Junejo, J Bowring, A N Rosenthal, O Richel, M Nathan, H J C de Vries, J M Prins · 2026
Read Long‐term outcome of ablation for anal HSIL: Achieving HSIL‐free status is key—A UK‐based retrospective cohort study by T Cuming, K Rozemeijer, E Farrow, C Cappello, B Wait, M Junejo, J Bowring, A N Rosenthal, O Richel, M Nathan, H J C de Vries, J M Prins (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13578555.txt.
Description
Cuming and co-authors follow men after laser treatment for precancerous anal lesions in a 2026 study. One hundred thirty-six men at a British center entered long surveillance. Most were men who have sex with men, and most lived with HIV. Watch time ran a median of five and a half years.
Nine in ten men cleared their lesions after one or two treatments. Clearing took a median of seven months from first treatment. Men who never cleared faced far higher cancer rates, over a third versus under one percent. Large first lesions and low past immune counts marked the never clear group. Close watch matters most for men whose lesions persist.
Catalog record
| CREATOR | T Cuming, K Rozemeijer, E Farrow, C Cappello, B Wait, M Junejo, J Bowring, A N Rosenthal, O Richel, M Nathan, H J C de Vries, J M Prins |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |